| Name | Title | Contact Details |
|---|
We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
LESS PAIN More Living At Southlake Orthopaedics, you can trust us to provide personalized and compassionate care, utilizing the most advanced medical technology available. Our clinics are home to the expertise of physicians in every orthopaedic special...
Draxis Pharma is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.